Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Chimera: Buy, Sell, or Hold?

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

Like many REIT investors, Chimera (NYSE: CIM  ) shareholders aren't exactly satisfied with what happened to their stock in 2011. Even including dividends, they're now 28% in the hole.

But the past is the past, and short-term price movements tell us nothing about where a stock will go in the future. So, is Chimera a buy, a sell, or a hold today?

What you need to know about Chimera
The first thing you need to know is that Chimera follows a different model than most other residential mortgage REITs. Whereas Annaly (NYSE: NLY  ) , American Capital Agency (Nasdaq: AGNC  ) , and Armour Residential (NYSE: ARR  ) use lots of leverage to buy safe Fannie- and Freddie-guaranteed loans, Chimera (and to a lesser extent Invesco (NYSE: IVR  ) ) use less leverage to purchase riskier, higher-yielding assets.

These days, investors have apparently soured on that model:


Percentage of Agency Securities


Chimera 41%                  0.89
Invesco 71% 0.91
Annaly Capital 100% 1.02
Armour Residential 100% 1.04                         
American Capital Agency 100% 1.08

Source: S&P Capital IQ.

With the trouble brewing in financial markets these days, plus the fact that more than 80% of Chimera's assets are junk or unrated, you can see why investors are a bit skittish. All of the companies above recorded gains on asset sales in their most recently reported quarters, ranging from $6 million for Armour to $177 million for American Capital Agency, while Chimera reported a $41 million loss.

That being said, there are some advantages to Chimera's position. The big one is that it's able to take advantage of market mispricings. Whereas each of the other REITs' fate will largely be determined by interest rates and prepayment speeds, Chimera has a greater ability to place idiosyncratic bets.

Of course, flexibility cuts both ways. It amplifies the importance of Chimera's management team -- for better or for worse.

The management behind the curtain
So how can we tell if Chimera's investing style is more likely to be beneficial? To paraphrase Warren Buffett, we want to see properly incented and competent management.

Chimera CEO Matthew Lambiase owns $1.5 million of his company. Although the shares were given to him in the form of a restricted stock award by the company, it's actually a pretty significant sum in relation to his salary. (He also owns $600,000 worth of Annaly Capital, which manages Chimera.)

It's not easy to tell how talented Chimera's management is. That's the nature of Wall Street; it's tough to separate skill from luck, and we don't exactly have a long company history to go by. That being said, what we do know is that Annaly's management has done quite well through various markets over the past few decades, and Chimera's team has their confidence.

The most important thing
How Chimera fares in 2012 -- more than any other REIT above -- will depend on how well its management team is able to take advantage of new investment opportunities and manage risk. The trouble brewing in financial markets and the jumbo market could present some attractive bargains for this opportunistic REIT.

Trading at a discount to book value, Chimera could be a buy, but only if you believe in the team leading it. If you're looking for other great dividend stocks with much simpler, perhaps safer, business models, check out "Secure Your Future With 11 Rock-Solid Dividend Stocks," a special report from The Motley Fool about some serious dividend dynamos. I invite you to grab a free copy so you can discover everything you need to know about these 11 generous dividend payers -- simply click here.

Ilan Moscovitz doesn't own shares of any company mentioned. The Motley Fool owns shares of Annaly Capital Management and Chimera Investment. Motley Fool newsletter services have recommended buying shares of Annaly Capital Management. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Read/Post Comments (5) | Recommend This Article (6)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On January 23, 2012, at 1:55 PM, nontechie wrote:

    I bought Chimera because it was created to take advantage of the chaos in housing markets and finance . . . by the very smart people who have successfully run Annaly and who understand these markets better than I do or than the author of this article does. I did not expect to make money in it beyond the dividend until housing normalizes. That's how it works with distressed assets--the payoff comes when the stress is relieved.

    Meanwhile, I am nearly even on a total return basis because of the very high yield. I am satisfied and continue to collect my dividend while waiting.

    Buying Chimera now, of course, might be an even better proposition than when I bought it since I think most of the losses have been seen. But we'll see.

  • Report this Comment On January 23, 2012, at 3:00 PM, vaderblue wrote:

    Buying CIM now is less riskier than 2011.

    We all took a beating buying this stock in 2011.

    I have since pulled out and putting ARR in it's

    place. Not sure if I will be an investor again.

    We still have mountains to climb and it' s not just

    their management managing risk but we must

    evaluate these distressed assets as well.

    I believe anyone can buy just about any stock

    and make money if: They wait and watch those

    stocks and buy rock bottom. Look for the bottom

    but has CIM really hit rock bottom. Will it see

    $2.50 this year. It seems last year just when I thought this stock had bottomed it would pull

    back more and more and more. From >$4 to mid

    $2.50 range.

    We all look for some form of appreciation s well

    as dividends but I lost faith in Chemera.

    Good luck in 2012

  • Report this Comment On January 24, 2012, at 11:36 AM, plange01 wrote:

    cim is a great stock but buy it in the $2.50 range collect its great dividend than after its record date sell it for whatever more you can get and do it all over every three months...

  • Report this Comment On January 24, 2012, at 11:38 AM, plange01 wrote:

    in 2011 cim was above $4 for the single reason the company had a buyout offer it for good reason choose not to take..2.50 to $3.00 is about its range for now...

  • Report this Comment On January 26, 2012, at 9:47 PM, 1caflash wrote:

    It was revealed that Wells Fargo recently Upped its Chimera stake by over One Million shares. There is another report that NLY's CEO is fighting Cancer. Let's wish Him successful treatments. CIM is in my DRIP.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1763385, ~/Articles/ArticleHandler.aspx, 10/23/2016 4:44:52 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 1 day ago Sponsored by:
DOW 18,145.71 -16.64 -0.09%
S&P 500 2,141.16 -0.18 -0.01%
NASD 5,257.40 15.57 0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 4:00 PM
CIM $15.40 Up +0.10 +0.65%
Chimera Investment CAPS Rating: ***
AGNC $19.48 Down +0.00 +0.00%
American Capital A… CAPS Rating: ***
ARR $22.46 Up +0.10 +0.45%
ARMOUR Residential… CAPS Rating: ***
IVR $14.80 Up +0.04 +0.27%
Invesco Mortgage C… CAPS Rating: *****
NLY $10.08 Down -0.05 -0.49%
Annaly Capital Man… CAPS Rating: ****